OQS
AURA icon

Occudo Quantitative Strategies’s Aura Biosciences AURA Stock Holding History

Occudo Quantitative Strategies’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-19,472
Closed -$120K – 689
2025
Q3 		$120K Buy
+19,472
New +$127K 0.01% 611

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Occudo Quantitative Strategies's AURA Position: Q4 2025 in Review

Occudo Quantitative Strategies sold out of Aura Biosciences (AURA) in Q4 2025, closing a stake of 19,472 shares — an estimated $120K sold.

Occudo Quantitative Strategies first reported a position in AURA in Q3 2025 and held it in 1 quarter. The position peaked at $120K in Q3 2025. 117 funds tracked by Wall St. Rank hold AURA as of Q4 2025.

  • Occudo Quantitative Strategies reported no remaining Aura Biosciences position as of Q4 2025 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 19,472 Aura Biosciences shares in Q4 2025, an estimated $120K.
  • Occudo Quantitative Strategies first reported a position in Aura Biosciences in Q3 2025 and held it in 1 quarter.
  • Occudo Quantitative Strategies's Aura Biosciences position peaked at $120K in Q3 2025.
  • 117 funds tracked by Wall St. Rank held Aura Biosciences as of Q4 2025.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2025, filed 17 Feb 2026.